Modulation of lncRNA links endothelial glycocalyx to vascular dysfunction of tyrosine kinase inhibitor(vol 119, pg 1997, 2023)

被引：0
|
作者：
Nukala, Sarath Babu
Jousma, Jordan
Yan, Gege
Han, Zhenbo
Kwon, Youjeong
Cho, Yoonje
Liu, Chuyu
Gagnon, Keith
Pinho, Sandra
Rehman, Jalees
Shao, Ning-Yi
Ong, Sang-Bing
Lee, Won Hee
Ong, Sang-Ging
机构：
来源：
CARDIOVASCULAR RESEARCH | 2024年 / 120卷 / 17期
关键词：
D O I：
10.1093/cvr/cvae233
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2321 / 2321
页数：1
相关论文
共 12 条
  • [1] Modulation of lncRNA links endothelial glycocalyx to vascular dysfunction of tyrosine kinase inhibitor
    Nukala, Sarath Babu
    Jousma, Jordan
    Yan, Gege
    Han, Zhenbo
    Kwon, Youjeong
    Cho, Yoonje
    Liu, Chuyu
    Gagnon, Keith
    Pinho, Sandra
    Rehman, Jalees
    Shao, Ning-Yi
    Ong, Sang-Bing
    Lee, Won Hee
    Ong, Sang-Ging
    CARDIOVASCULAR RESEARCH, 2023, 119 (10) : 1997 - 2013
  • [2] Apolipoprotein CIII links hyperlipidemia with vascular endothelial cell dysfunction (vol 118, pg 731, 2008)
    Kawakami, A.
    Osaka, M.
    Tani, M.
    Azuma, H.
    Sacks, F. M.
    Shimokado, K.
    Yoshida, M.
    CIRCULATION, 2012, 125 (06) : E362 - E362
  • [3] Modulation of interleukin 1β production in macrophages stimulated with lipopolysaccharide by the protein kinase inhibitor staurosporine (vol 4, pg 251, 1997)
    Schilling, D
    Brauburger, J
    Ruiner, W
    Nixdorff, K
    JOURNAL OF ENDOTOXIN RESEARCH, 1997, 4 (06): : 466 - 466
  • [4] Design, synthesis, and evaluation of orally active benzimidazoles and benzoxazoles as vascular endothelial growth factor-2 receptor tyrosine kinase inhibitors (vol 50, pg 4351, 2007)
    Potashman, Michele H.
    Bready, James
    Coxon, Angela
    DeMelfi, Thomas M., Jr.
    DiPietro, Lucian
    Doerr, Nicholas
    Elbaum, Paniel
    Estrada, Juan
    Gallant, Paul
    Germain, Julie
    Gu, Yan
    Harmange, Jean-Christophe
    Kaufman, Stephen A.
    Kendall, Rick
    Kim, Joseph L.
    Kumar, Gondi N.
    Long, Alexander M.
    Neervannan, Seshadri
    Patel, Vinod F.
    Polverino, Anthony
    Rose, Paul
    van der Plas, Simon
    Whittington, Douglas
    Zanon, Roger
    Zhao, Huilin
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (03) : 699 - 699
  • [5] Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells (vol 119, pg 1109, 2009)
    Bellodi, Cristian
    Lidonnici, Maria Rosa
    Hamilton, Ashley
    Helgason, G. Vignir
    Soliera, Angela Rachele
    Ronchetti, Mattia
    Galavotti, Sara
    Young, Kenneth W.
    Selmi, Tommaso
    Yacobi, Rinat
    Van Etten, Richard A.
    Donato, Nick
    Hunter, Ann
    Dinsdale, David
    Tirro, Elena
    Vigneri, Paolo
    Nicotera, Pierluigi
    Dyer, Martin J.
    Holyoake, Tessa
    Salomoni, Paolo
    Calabretta, Bruno
    JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (08): : 3634 - 3634
  • [6] Modulation of Premetastatic Niche by the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Localized High-Risk Prostate Cancer Followed by Radical Prostatectomy: A Phase II Randomized Trial
    Maughan, Benjamin L.
    Pal, Sumanta K.
    Gill, David
    Boucher, Kenneth
    Martin, Christopher
    Salgia, Meghan
    Nussenzveig, Roberto
    Liu, Ting
    Hawks, Josiah L.
    Batten, Julia
    Nachaegari, Gayatri
    Stephenson, Robert
    Lowrance, William
    Jones, Jeremy
    Dechet, Christopher
    Agarwal, Neeraj
    ONCOLOGIST, 2018, 23 (12): : 1413 - +
  • [7] Proton Pump Inhibitors Decrease Soluble fms-Like Tyrosine Kinase-1 and Soluble Endoglin Secretion, Decrease Hypertension, and Rescue Endothelial Dysfunction (vol 69, pg 457, 2017)
    Onda
    HYPERTENSION, 2018, 71 (04) : E11 - E11
  • [8] Modulation of tumor immune microenvironment by TAS-115, a multi-receptor tyrosine kinase inhibitor, promotes antitumor immunity and contributes anti-PD-1 antibody therapy (vol 13, 8821, 2023)
    Shibutani, Toshihiro
    Goto, Risa
    Miyazaki, Isao
    Hashimoto, Akihiro
    Suzuki, Takamasa
    Ishida, Keiji
    Haruma, Tomonori
    Osada, Toshihiro
    Harada, Takafumi
    Fujita, Hidenori
    Ohkubo, Shuichi
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [9] CEP-7055: A novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models (vol 63, pg 5978, 2003)
    Ruggeri, B
    Singh, J
    Gingrich, D
    Angeles, T
    Albom, M
    Yang, S
    Chang, H
    Robinson, C
    Hunter, K
    Dobrzanski, P
    Jones-Bolin, S
    Pritchard, S
    Aimone, L
    Klein-Szanto, A
    Herbert, JM
    Bono, F
    Schaeffer, P
    Casellas, P
    Bourie, B
    Pili, R
    Isaacs, J
    Ator, M
    Hudkins, R
    Vaught, J
    Mallamo, J
    Dionne, C
    CANCER RESEARCH, 2003, 63 (21) : 7543 - 7543
  • [10] IL-4 and IL-13 activate the JAK2 tyrosine kinase and stat b in cultured human vascular endothelial cells through a common pathway that does not involve the gamma(c) chain (vol 98, pg 604, 1996)
    PalmerCrocker, RL
    Hughes, CCW
    Pober, JS
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (09): : 2187 - 2187
12